ERBB2 and breast cancer: However, CHRM3 gene expression showed an increased risk in breast cancer (BRCA-LumA); M4 receptor gene expression showed an increased risk in BRCA-Basal, but a decreased risk in BRCA-Her2 adjusted by stage clinical factor.